The market is dominated by domestic suppliers, as imports account for 7.2% of total market size in 2020. B2B drives market demand, with B2B spending representing 82.5% of total demand in 2020. India has the fourth largest market size for pharmaceuticals in the region, with demand reaching USD21.5 billion in 2020. Lupin Ltd is the largest company in India, generating 4.5% of the industry’s total production value in 2020. The industry is fragmented, with the top five companies generating 20.5% of total production value in 2020. The total number of companies decreases in 2020, to 305,508 units. The costs of the industry decrease by 8.5% in 2020, largely driven by declining B2B costs. The industry’s profitability decreases and stands at 17.9% of production value in 2020, the 11th highest in the region. With production value of USD28.4 billion, India accounts for 4.5% of the Asia Pacific total in 2020.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This Euromonitor industrial report provides unique information on Pharmaceuticals in India: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in India: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page